Anti-FLT3 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-FLT3 CAR-T cells, covering 2025-08-14 to 2025-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML [Phase 1]